Prespecified secondary analysis of NEO-MINDSET (3410 ACS patients after PCI): early P2Y12 inhibitor monotherapy had more ischaemic events than DAPT in STEMI (8.2% vs 5.2%; HR 1.60) but not NSTE-ACS (5.1% vs 6.0%); bleeding was lower in both.
Secondary analysisn = 3,410
Tavares et al. Potent P2Y12 Inhibitor Monotherapy vs DAPT After PCI in Patients With and Without STEMI: The NEO-MINDSET Substudy